Yasutoshi Nozaki

Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice

Satoshi Tanaka, Hayato Hikita, Tomohide Tatsumi et al. · Hepatology · 2016 · 361 citations

Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy

Yuta Myojin, Takahiro Kodama, Ryotaro Sakamori et al. · Cancers · 2022 · 80 citations · Full text

Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy

Takayuki Matsumae, Takahiro Kodama, Yuta Myojin et al. · Cancers · 2022 · 62 citations · Full text

Immunology, Pathology, Immunotherapy +17

DNase II activated by the mitochondrial apoptotic pathway regulates RIP1-dependent non-apoptotic hepatocyte death via the TLR9/IFN-β signaling pathway

Yoshinobu Saito, Hayato Hikita, Yasutoshi Nozaki et al. · Cell Death and Differentiation · 2018 · 60 citations · Full text

Dnase Ii, Mitochondrial Function, Medicine +8

Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma

Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada et al. · Hepatology Research · 2022 · 55 citations